Last edited by Doulabar
Monday, April 27, 2020 | History

5 edition of Advances in Antiviral Drug Design, Volume 1 (Advances in Antiviral Drug Design) found in the catalog.

Advances in Antiviral Drug Design, Volume 1 (Advances in Antiviral Drug Design)

  • 262 Want to read
  • 16 Currently reading

Published by Elsevier Science .
Written in English

    Subjects:
  • Medical microbiology & virology,
  • Science,
  • Science/Mathematics,
  • Life Sciences - Biology - Molecular Biology,
  • Pharmacology,
  • Science / Microbiology,
  • Life Sciences - Biology - Microbiology

  • The Physical Object
    FormatHardcover
    Number of Pages342
    ID Numbers
    Open LibraryOL12094131M
    ISBN 101559381558
    ISBN 109781559381550


Share this book
You might also like
Chemistry for changing times

Chemistry for changing times

Report on an Exploration in the Yukon District, N.W.T and Adjacent Northern Portion of British Columbia, 1887.

Report on an Exploration in the Yukon District, N.W.T and Adjacent Northern Portion of British Columbia, 1887.

Green Bay Packers Super Deluxe 2006 Calendar

Green Bay Packers Super Deluxe 2006 Calendar

The heart of the country

The heart of the country

National curriculum technology at key stage 3

National curriculum technology at key stage 3

Lily Pond Large Turley Biblecover Grape: This is the Day Which the Lord Hath Made Psalm 118:24

Lily Pond Large Turley Biblecover Grape: This is the Day Which the Lord Hath Made Psalm 118:24

Readings on production planning and control.

Readings on production planning and control.

The Last blewointment anthology

The Last blewointment anthology

child from the sea.

child from the sea.

Role of health care institutions in satisfying the reading needs of residents with print limitations

Role of health care institutions in satisfying the reading needs of residents with print limitations

Abacus 3

Abacus 3

State solvency regulation of property-casualty and life insurance companies

State solvency regulation of property-casualty and life insurance companies

text-book of psychology for nurses.

text-book of psychology for nurses.

Advances in Antiviral Drug Design, Volume 1 (Advances in Antiviral Drug Design) by E. De Clercq Download PDF EPUB FB2

Series: Advances in Antiviral Volume 1 book Design (Volume 1) (Book 1) Hardcover: pages; Publisher: Elsevier Science; 1 edition (J ) Language: English; ISBN ; ISBN ; Product Dimensions: x x inches Shipping Weight: pounds; Customer Reviews: Be the first to write a review.

The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs). Volume 1 book Advances In Antiviral Drug Design [E. De Clercq] on *FREE* shipping on qualifying offers.

Regularly reviewing the state-of-the-art developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship.

The purpose of the series, Advances in Antiviral Drug Design, is to regularly provide an account on the chemistry of the new antiviral agents (whether licensed or en route of licensing), and to discuss their structure-activity relationship, width of activity spectrum, and Advances in Antiviral Drug Design of action.

The purpose of the series on Advances in Antiviral Drug Design is to regularly review the "state of the art" on emerging new developments in the antiviral drug research field, thereby spanning the conceptual design and chemical synthesis of new antiviral.

The five topics covered in this third volume of Advances in Antiviral Drug Design are in the front line of the present endeavors towards the chemotherapy of virus infections. They pertain to the combat against three of the most important virus infections of current times: HIV, HBV, and influenza virus.

Advances in Antiviral Drug Design. Articles and issues. Latest volume All volumes. Search in this book series. Edited by E.

De Clercq. Volume 5, Pages () Download full volume. Previous volume. Next volume. Actions for selected chapters. Select all /. Search in this book series. Advances in Antiviral Drug Design. Edited by E. De Clercq.

Volume 2, Pages () Download full volume. Previous volume. Next volume. Actions for selected chapters. Select all / Deselect all. Download PDFs Export citations.

Show all chapter previews Show all chapter previews. Search in this book series. Advances in Antiviral Drug Design. Volume 4, Pages () Download full volume. Previous volume. Next volume. Actions for selected chapters.

Select all / Deselect all. Download PDFs Export citations. Show all chapter previews Show all chapter previews. Advances in Antiviral Drug Design. Latest volume All volumes. Search in this book series. Edited by E. De Clercq. Volume 3, Pages () Download full volume.

Previous volume. Next volume. Actions for selected chapters. Select all / Deselect all. Download PDFs Export citations.

The focus of the book will be on capturing tactical aspects of problem solving in antiviral drug design, an approach that will hold special appeal for those engaged in antiviral drug development but will also appeal to the broader chemistry community based on its focus on tactical aspects of drug design.

The six topics covered in this fourth volume of Advances in Antiviral Drug Design are in the front line of the present endeavors towards the design and development of new therapeutic agents for virus infections.

They pertain to the combat against three of the most important viral pathogens of current times: HIV, HBV, influenza virus and herpesviruses.

Advances in Antiviral Drug Design. Volume 3 Edited by E. De Clercq (Katholieke Universiteit Leuven, Belgium). JAI Press: Stamford, CT.

xii + pp. $ ISBN Terence A. KellyAuthor: Terence A. Kelly. Strategies in the design of antiviral drugs. Erik De Clercq 1 Nature Reviews Drug Discovery volume 1, Science Advances ()Cited by: The general idea behind modern antiviral drug design is to identify viral proteins, or parts of proteins, that can be disabled.

Once targets are identified, candidate drugs can be selected, either from drugs already known to have appropriate effects, or by actually designing the candidate at the molecular level with a computer-aided design : Shin-Ru Shih, Amy L.

Greer, Jürgen K. Rockstroh, Joel K. Kelso, Carlo Torti, Jazmin Duque. The five topics covered in this third volume of Advances in Antiviral Drug Design are in the front line of the present endeavors towards the chemotherapy of virus infections.

They pertain to the combat against three of the most important virus infections of current times: HIV, HBV, and influenza : Hardcover.

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

Advances in Antiviral Drug Design (ISSN Book 4) - Kindle edition by E. De Clercq. Download it once and read it on your Kindle device, PC, phones or tablets. Use features like bookmarks, note taking and highlighting while reading Advances in Antiviral Drug Design (ISSN Book 4). Title: Recent Advances in Antiviral Agents: Antiviral Drug Discovery for Hepatitis Viruses VOLUME: 12 ISSUE: 11 Author(s):K.

Tanikawa Affiliation:International Institute forLiver Research, Kurume Research Center, Hyakunen Kouen, Kurume, Japan. Keywords:anti-hepatitis virus agent, Liver disease, HDV, HCV, HBV Abstract: Hepatitis B virus (HBV)- or hepatitis C virus (HCV)- Cited by: 6.

Volume 3 of Advances in Antiviral Drug Design is keeping up with the recent progress made in the field of antiviral drug research and highlights five specific directions that have opened new avenues for the treatment of virus infections.

First, the use of lamivudine (3TC) for the treatment of HIV infections, and its more recent introduction for the treatment of hepatitis B virus (HBV /5(3).

The purpose of the series on Advances in Antiviral Drug Design is to regularly review the "state of the art" on emerging new developments in the antiviral drug research field, thereby spanning the conceptual design and chemical synthesis of new antiviral compounds, their structure-activity relationship, mechanism and target(s) of action, pharmacological behavior, antiviral activity spectrum Format: Paperback.

Title: Recent Advances in Flavivirus Antiviral Drug Discovery and Vaccine Development VOLUME: 1 ISSUE: 1 Author(s):Debashish Ray and Pei-Yong Shi Affiliation New Scotland Avenue,Wadsworth Center, New York State Department of Health, Albany, NewYorkUSA; Keywords:Flavivirus, vaccine, antiviral, drug discovery, RNA virus, inhibitor Cited by: Antiviral Drugs.

The articles that appear in Antiviral Drugs - Aspects of Clinical Use and Recent Advances cover several topics that reflect the varied mechanisms of viral disease pathogenesis and treatment. Clinical management and new developments in the treatment of virus-related diseases are the two main sections of the by: 6.

Find many great new & used options and get the best deals for Advances in Antiviral Drug Design: Advances in Antiviral Drug Design 5 (, Hardcover) at the best online prices at eBay.

Free shipping for many products. The fourth volume of Advances in Antiviral Drug Design is keeping up with the recent progress made in the broad field of antiviral drug research and encompasses six specific directions that have opened new avenues for the treatment of HIV and other virus infections.

First, as the introductory chapter, the different new anti-HIV agents that are now in preclinical or clinical development are. Title: Recent Advances in Antiviral Agents: Antiviral Drug Discovery for Hepatitis Viruses VOLUME: 12 ISSUE: 11 Author(s):K.

Tanikawa Affiliation:International Institute forLiver Research, Kurume Research Center, Hyakunen Kouen, Kurume, Japan. Keywords:anti-hepatitis virus agent, Liver disease, HDV, HCV, HBV Abstract: Hepatitis B virus (HBV)- or hepatitis C virus (HCV).

This is the first special topic volume, collected from articles within Progress and Drug Research dealing with new antiviral agents. The editors have chosen an important range of topics – concentrating on only one aspect of HIV (a good idea given the breadth of antivirals for HIV), and agents for Author: William Rawlinson.

The book Advances in Studies on Enzyme Inhibitors as Drugs edited by eminent scientist Satya P. Gupta, covers the most recent development on design and discovery of the most useful drugs acting against several life threatening diseases such as cancer, viral infections and many others in two volumes.

This is the first special topic volume, collected from articles within Progress and Drug Research dealing with new antiviral agents. The editors have chosen an important range of topics – concentrating on only one aspect of HIV (a good idea given the breadth of antivirals for HIV), and agents for influenza, hepatitis C, hepatitis B, herpesviruses and : William Rawlinson.

Get this from a library. Advances in antiviral drug design. Vol. [E de Clercq;] -- The fourth volume of Advances in Antiviral Drug Design is keeping up with the recent progress made in the broad field of antiviral drug research and encompasses six specific directions that have.

The currently licensed antiviral drugs target viral factors and are prone to viral resistance. In recent years, a few endogenous small molecules from host, such as estradiol and omega-3 polyunsaturated fatty acid (PUFA)-derived lipid mediator protection D1 (PD1), were demonstrated to be capable of inhibiting IAV infection.

Advances in antiviral drug design. Volume 2. [Erik De Clercq;] This book assesses the role of S-adenosylhornocysteine (AdoHcy) hydrolase as target for the design of antiviral agents with Read more Rating: (not yet # Advances in antiviral drug design.

The purpose of the series on Advances in Antiviral Drug Design is to regularly review the "state of the art" on emerging new developments in the antiviral drug research field, thereby spanning the conceptual design and chemical synthesis of new antiviral compounds, their structure-activity relationship, mechanism and target(s) of action, pharmacological behavior, antiviral activity.

Volume 3 of Advances in Antiviral Drug Design is keeping up with the recent progress made in the field of antiviral drug research and highlights five specific directions that have opened new avenues for the treatment of virus infections.

First, the use of lamivudine (3TC) for the treatment of HIV infections, and its more recent introduction for the treatment of hepatitis B. Get this from a library. Advances in antiviral drug design. Volume 5. [Erik De Clercq;] -- Regularly reviewing the ""state-of-the-art"" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds.

This Special Issue will cover the current advances in small-molecule and biologic therapy against NIDs, biomolecular structure and drug design, and all of the relevant aspects for the development and expansion of novel chemical and biomolecular NID treatments. We live in a time of rapid development of antiviral compounds.

For selective chemotherapy of viral infections, a drug should inhibit virus replication when used at concentrations not detrimental to the host. A number of antiviral drugs have been formally licensed and are widely used for the chemotherapy of specific viral infections.

Other antiviral agents are being by: 7. Antiviral drug, any agent used in the treatment of an infectious disease caused by a virus. Antiviral agents generally are designed to block viral replication or disable viral proteins. Examples of antiviral drugs include agents to combat herpes viruses, influenza viruses, and HIV.

Advances in Pharmacological Sciences page. Keywords: issn,Advances in Pharmacological Sciences,Egyptjournal. Join the conversation about this journal.

This book presents a comprehensive view of the development in the fields of pharmacological protection of the myocardium and the pharmacology of the vascular system. 83 MB10, 1 Antiviral Agents Scott M. Hammer, M.D. Challenges to the Development of Effective Antiviral Agents • Myriad number of agents • Need knowledge of replication at molecular level to define targets – Viruses as intracellular parasites make targeting more difficult to avoid host toxicityFile Size: KB.

Antiviral agents: advances and problems Rawlinson, William Edited by Ernst Jucker Published by Birkhäuser ISBN: 3‐‐‐1, Price 65 Euros This is the first special topic volume, collected from articles within Progress and Drug Research dealing with new antiviral agents.

The editors have chosen an important range Author: Rawlinson, William.JAI Press Advances in International Accounting United States JAI Press Advances in Antiviral Drug Design United States JAI Press Biomembranes: A Multi-Volume Treatise Netherlands JAI Press Advances in DNA Sequence-Specific Agents United States JAI Press International Research in the Business Disciplines United States.Antiviral drugs are a class of medication used for treating viral infections.

Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.

Antiviral drugs are one class of antimicrobials, a larger group which also.